LCT/MCM6 Gene Test (Lactase Persistence & Lactose Intolerance)

• Identify whether you carry lactase persistence or lactase non-persistence variants in LCT/MCM6 that strongly influence adult lactose tolerance.
• Help explain symptoms such as bloating, gas, abdominal pain, diarrhoea, or urgency after dairy, and distinguish primary lactose intolerance from other causes of gut discomfort.
• Inform personalised nutrition strategies, including whether you are likely to tolerate regular dairy, need to limit lactose, or may benefit from lactose-free products or lactase support.
• Provide context for calcium, vitamin D, and protein planning if you need to restrict lactose-containing dairy, especially in life stages with higher bone demands.
• Clarify your baseline lactase activity profile alongside microbiome and gut markers, so you can fine-tune diet with confidence rather than through repeated trial and error.

The LCT gene encodes lactase-phlorizin hydrolase, commonly called lactase, the enzyme on the brush border of the small intestine that breaks down lactose into glucose and galactose for absorption. Lactase activity is typically high in infancy and declines after weaning in most of the global population.

The MCM6 gene sits near LCT and contains regulatory elements that control LCT expression in adulthood. Specific variants in MCM6 introns, such as rs4988235 and rs182549, act as switches that either maintain lactase expression (lactase persistence) or allow it to decline (lactase non-persistence). Together, LCT/MCM6 variants explain much of the genetic basis of adult lactose tolerance or intolerance in many populations.

LCT/MCM6 sits at the heart of lactose digestion. When lactase is active on the intestinal surface, it hydrolyses lactose from milk and dairy products into glucose and galactose, which are then absorbed and used for energy or stored as glycogen. This process prevents lactose from reaching the colon in large amounts.

MCM6 regulatory variants determine how long LCT stays switched on after childhood. Lactase persistence variants keep lactase expression high into adult life, allowing continued digestion of lactose. Lactase non-persistence variants lead to downregulation of LCT in later childhood and adolescence, reducing lactase activity so that lactose passes into the colon, where it is fermented by bacteria, producing gas and osmotic effects that drive typical lactose intolerance symptoms.

LCT/MCM6 contributes to three interconnected systems: digestion and comfort after dairy, overall nutrient intake and bone health, and broader metabolic and microbiome patterns. For people with lactase persistence, dairy can be a convenient source of protein, calcium, and other nutrients without causing gut distress.

For those with lactase non-persistence, regular high-lactose intake can lead to bloating, pain, diarrhoea, and a tendency to avoid dairy altogether, sometimes without clear substitutes for calcium, iodine, and vitamin D. This can have knock-on effects on bone density and long-term musculoskeletal health if not addressed. At the same time, many people with non-persistent genotypes tolerate small amounts of lactose, fermented dairy, or lactose-free products well, especially when the microbiome and gut health are supported.

It is easy to assume that LCT/MCM6 genotyping, hydrogen breath tests, and elimination diets provide the same information, but they answer different questions. LCT/MCM6 genotyping reveals your inherited potential for lactase persistence or non-persistence and remains constant over life. It tells you whether low lactase is likely to be the root cause of lactose intolerance.

Hydrogen or methane breath tests measure how your gut handles a specific lactose load on a particular day, reflecting both lactase activity and microbial fermentation. Elimination and re-challenge diets explore symptom patterns in real-world eating but can be confounded by other food sensitivities and placebo or nocebo effects. Combining LCT/MCM6 genetics with breath tests, symptom tracking, and microbiome insights gives a much clearer, more personalised picture.

The influence of LCT/MCM6 variants is shaped by dose, microbiome composition, gut health, and broader diet. Several modifiable factors can either buffer genetic effects or amplify them.

• Lactose dose and pattern: Many people with lactase non-persistence tolerate small lactose doses, especially with meals, but develop symptoms with large glasses of milk or multiple dairy servings. Spacing and portion size make a real difference.
• Type of dairy: Fermented dairy such as yoghurt and many cheeses contain less lactose and beneficial bacteria, and are often better tolerated than fresh milk in lactase non-persistent individuals.
• Microbiome composition: Some gut bacteria are efficient at processing lactose with fewer symptoms, while others generate more gas and osmotic load. Microbiome balance, fibre intake, and overall diet influence symptom severity.
• Gut barrier and motility: Co-existing IBS, coeliac disease, SIBO, infections, or general gut barrier issues can magnify lactose-related symptoms. Addressing these can improve tolerance even if genetics indicate non-persistence.
• Total carbohydrate and FODMAP load: High FODMAP or high sugar diets can add extra fermentable substrates and osmotic load, worsening symptoms in people with reduced lactase activity.
• Life stage and hormonal status: Pregnancy, stress, and hormonal shifts can change gut motility and sensitivity, temporarily altering how strongly LCT/MCM6 patterns show up day to day.

Yes. Many people with lactase non-persistence genotypes report little or no symptoms, particularly if their dairy intake is modest, mainly fermented, or spread across the day, and if their microbiome and gut health are robust. Others may have mild symptoms they accept as "normal" until they experiment with targeted changes.

Conversely, some people with lactase persistence genotypes can still experience discomfort after dairy due to other issues, such as milk protein sensitivity, IBS, high FODMAP load, or broader dysbiosis. Genetics explains a large part of lactose tolerance, but not every aspect of how you feel after specific foods.

LCT/MCM6 genotypes mainly differ in whether they support lactase persistence or non-persistence into adulthood, and therefore how likely you are to develop primary lactose intolerance. Understanding your pattern helps you design a dairy strategy that fits your biology.

• Lactase persistence genotypes (for example T/T or C/T at key MCM6 regulatory sites such as -13910): These patterns are associated with continued high lactase expression into adulthood and a higher likelihood of tolerating regular lactose intake without symptoms.
• Lactase non-persistence genotypes (for example C/C at -13910 or similar patterns in LCT promoter regions): These patterns are associated with adult-type hypolactasia and a higher likelihood of lactose intolerance symptoms with typical dairy intakes, especially in higher doses.
• Mixed or population-specific variants: Different populations have distinct lactase persistence variants within MCM6 and LCT regulatory regions. Some panels capture multiple variants to reflect diverse ancestry patterns and provide more accurate predictions.

For DNA-based LCT/MCM6 testing, preparation is simple because your genotype does not change with diet, microbiome shifts, or recent symptoms. The key step is deciding how you will use the results, for example to guide dairy intake, explore alternative calcium sources, or refine IBS or gut health strategies.

Cheek swab, saliva, or blood-based LCT/MCM6 genotyping does not require fasting. If you are combining genetic testing with breath tests, stool analysis, or blood work, follow the specific preparation instructions for those tests, which may include fasting or pausing certain supplements or medications.

An LCT/MCM6 test is most valuable when the result will change how you approach dairy and gut health, rather than as a curiosity. It becomes particularly informative when combined with symptom history and, where needed, functional gut testing.

• Recurrent symptoms after dairy: If you regularly experience bloating, gas, diarrhoea, or abdominal pain after milk or ice cream, LCT/MCM6 testing can clarify whether primary lactose intolerance is likely and help you build a more precise plan.
• IBS or functional gut symptoms: In IBS or similar conditions, identifying lactase non-persistence can simplify your diet strategy and reduce guesswork, while persistence genotypes can prompt you to look beyond lactose.
• Planning for bone and metabolic health: If you are considering restricting dairy for gut reasons, knowing your genetic lactase status can guide how firmly you need to limit lactose and where to focus on replacing calcium, iodine, protein, and vitamin D.
• Family and life stage planning: In families with strong lactose intolerance patterns or in people planning pregnancy or older-age bone strategies, LCT/MCM6 testing helps structure sustainable food plans.